These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28154710)

  • 21. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
    Muula AS
    Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International response to the HIV/AIDS epidemic: planning for success.
    Piot P; Coll Seck AM
    Bull World Health Organ; 2001; 79(12):1106-12. PubMed ID: 11799442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women and AIDS in Zimbabwe: the making of an epidemic.
    Bassett MT; Mhloyi M
    Int J Health Serv; 1991; 21(1):143-56. PubMed ID: 2004868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [AIDS treatment in Africa: the risk of antiretroviral resistance].
    Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
    Kazatchkine M; Moatti JP
    Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
    [No Abstract]   [Full Text] [Related]  

  • 27. Fighting AIDS in Sub-Saharan Africa: is a public- private partnership a viable paradigm?
    Clark PA; O'Brien K
    Med Sci Monit; 2003 Sep; 9(9):ET28-39. PubMed ID: 12960920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to pay for AIDS treatment: myths and realities.
    Binswanger HP
    Lancet; 2003 Oct; 362(9390):1152-3. PubMed ID: 14550705
    [No Abstract]   [Full Text] [Related]  

  • 29. The human immunodeficiency virus, (HIV-1), pandemic: cellular therapies, stem cells and biobanking.
    Stephens LL; Swanepoel CC; Van Rooyen BA; Abayomi EA
    Transfus Apher Sci; 2013 Aug; 49(1):9-11. PubMed ID: 23769172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.
    Lecher S; Ellenberger D; Kim AA; Fonjungo PN; Agolory S; Borget MY; Broyles L; Carmona S; Chipungu G; De Cock KM; Deyde V; Downer M; Gupta S; Kaplan JE; Kiyaga C; Knight N; MacLeod W; Makumbi B; Muttai H; Mwangi C; Mwangi JW; Mwasekaga M; Ng'Ang'A LW; Pillay Y; Sarr A; Sawadogo S; Singer D; Stevens W; Toure CA; Nkengasong J
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1287-90. PubMed ID: 26605986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV/AIDS epidemiology.
    Todd C
    Lancet; 2000 Oct; 356(9238):1357-8. PubMed ID: 11073053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. South Africa begins implementing ambitious HIV program. Government-funded initiative faces great challenges on several fronts.
    AIDS Alert; 2004 Aug; 19(8):suppl 1-2. PubMed ID: 15300949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [AIDS: the world's future is in 'their' hands, but comes from 'our' pockets; an impression from the World AIDS Conference in South Africa].
    Veeken H
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2363-7. PubMed ID: 11129973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The African Comprehensive HIV/AIDS Partnerships--a new role for multinational corporations in global health policy.
    Distlerath LM; Macdonald G
    Yale J Health Policy Law Ethics; 2004; 4(1):147-55. PubMed ID: 15052865
    [No Abstract]   [Full Text] [Related]  

  • 36. Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.
    Gupta R; Irwin A; Raviglione MC; Kim JY
    Lancet; 2004 Jan; 363(9405):320-4. PubMed ID: 14751708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basing treatment on rights rather than ability to pay: 3 by 5.
    Mukherjee J
    Lancet; 2004 Mar; 363(9414):1071-2. PubMed ID: 15065564
    [No Abstract]   [Full Text] [Related]  

  • 38. How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?
    Karaosmanoglu HK
    Curr HIV Res; 2021; 19(2):103-105. PubMed ID: 33243126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stirring the statistical pot.
    Bateman C
    S Afr Med J; 2004 Mar; 94(3):154-5. PubMed ID: 15098266
    [No Abstract]   [Full Text] [Related]  

  • 40. Marking Time in the Global HIV/AIDS Pandemic.
    Friedland G
    JAMA; 2016 Jul; 316(2):145-6. PubMed ID: 27404179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.